Patient Guide: A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 69 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05958407
Status: ACTIVE_NOT_RECRUITING
Condition: Atopic Dermatitis, Atopic Hand Eczema
Phase: PHASE3

Where You Can Participate

This study is available at 69 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Fort Smith, Arkansas
  • • Fountain Valley, California
  • • And 66 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy - Join Clinical Trial NCTNCT05958407

How to Join This Clinical Trial - NCTNCT05958407

Learn how to participate in this PHASE3 trial studying an investigational therapy for Atopic Dermatitis, Atopic Hand Eczema. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Atopic Dermatitis, Atopic Hand Eczema. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Atopic Dermatitis, Atopic Hand Eczema
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05958407 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 69 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35209 - United States

Status: Contact for availability

Clinical Research Site

Fort Smith, Arkansas 72916 - United States

Status: Contact for availability

Clinical Research Site

Fountain Valley, California 92708 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90025 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95816 - United States

Status: Contact for availability

Clinical Research Site

Farmington, Connecticut 06032 - United States

Status: Contact for availability

Clinical Research Site

Hialeah, Florida 33012 - United States

Status: Contact for availability

Clinical Research Site

Plainfield, Indiana 46168 - United States

Status: Contact for availability

Clinical Research Site

Louisville, Kentucky 40217 - United States

Status: Contact for availability

Clinical Research Site

New Orleans, Louisiana 70115 - United States

Status: Contact for availability

And 59 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Atopic Dermatitis, Atopic Hand Eczema:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships